GLP-1 relaxes the vascular endothelium in a nitric oxide (NO)-dependent fashion [5], and short-term (105 min) native GLP-1 infusion has been reported to improve vascular endothelial function in patients with type 2 diabetes [6]. This evidence concerns the gene GLP1R and type 2 diabetes mellitus.